Advertisement

More articles from Erratum

You have access
CORRECTION TO “P-GLYCOPROTEIN PLAYS A MAJOR ROLE IN THE EFFLUX OF FEXOFENADINE IN THE SMALL INTESTINE AND BLOOD-BRAIN BARRIER, BUT ONLY A LIMITED ROLE IN ITS BILIARY EXCRETION”
Drug Metabolism and Disposition June 2006, 34 (6) 1079; DOI: https://doi.org/10.1124/dmd.34.6.1079
You have access
CORRECTION TO “METABOLISM OF THE PSYCHOTOMIMETIC TRYPTAMINE DERIVATIVE 5-METHOXY-N,N-DIISOPROPYLTRYPTAMINE IN HUMANS: IDENTIFICATION AND QUANTIFICATION OF ITS URINARY METABOLITES”
Drug Metabolism and Disposition March 2006, 34 (3) 512; DOI: https://doi.org/10.1124/dmd.34.3.512
You have access
CORRECTIONS TO “HUMAN UDP-GLUCURONOSYLTRANSFERASES: ISOFORM SELECTIVITY AND KINETICS OF 4-METHYLUMBELLIFERONE AND 1-NAPHTHOL GLUCURONIDATION, EFFECTS OF ORGANIC SOLVENTS, AND INHIBITION BY DICLOFENAC AND PROBENECID”
Drug Metabolism and Disposition December 2005, 33 (12) 1925-1926; DOI: https://doi.org/10.1124/dmd.33.12.1925
You have access
CORRECTION TO “SUPPRESSION OF CYTOCHROME P450 2C11 BY AROMATIC HYDROCARBONS: MECHANISTIC INSIGHTS FROM STUDIES OF THE 5′-FLANKING REGION OF THE CYP2C11 GENE”
Drug Metabolism and Disposition December 2005, 33 (12) 1927; DOI: https://doi.org/10.1124/dmd.33.12.1927
You have access
CORRECTION TO “BIOACTIVATION OF THE NONTRICYCLIC ANTIDEPRESSANT NEFAZODONE TO A REACTIVE QUINONEIMINE SPECIES IN HUMAN LIVER MICROSOMES AND RECOMBINANT CYTOCHROME P450 3A4”
Drug Metabolism and Disposition May 2005, 33 (5) 696; DOI: https://doi.org/10.1124/dmd.33.5.
You have access
CORRECTION TO “TISSUE DISTRIBUTION, STABILITY, AND PHARMACOKINETICS OF APO2 LIGAND/TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND IN HUMAN COLON CARCINOMA COLO205 TUMOR-BEARING MICE”
Drug Metabolism and Disposition January 2005, 33 (1) 200-201; DOI: https://doi.org/10.1124/dmd.33.1.200
You have access
CORRECTION to September Issue of Drug Metabolism and Disposition
Drug Metabolism and Disposition November 2004, 32 (11) 1331; DOI: https://doi.org/10.1124/dmd.32.11.1331
You have access
CORRECTION TO “COMPARISON OF PREDICTION METHODS FOR IN VIVO CLEARANCE OF (S,S)-3-[3-(METHYLSULFONYL)PHENYL]-1-PROPYLPIPERIDINE HYDROCHLORIDE, A DOPAMINE D2 RECEPTOR ANTAGONIST, IN HUMANS”
Drug Metabolism and Disposition October 2004, 32 (10) 1199; DOI: https://doi.org/10.1124/dmd.32.10.1199
You have access
CORRECTION TO “GLUCURONIDATION OF THE OXIDATIVE CYTOCHROME P450-MEDIATED PHENOLIC METABOLITES OF THE ENDOCRINE DISRUPTOR PESTICIDE: METHOXYCHLOR BY HUMAN HEPATIC UDP-GLUCURONOSYL TRANSFERASES”
Drug Metabolism and Disposition September 2004, 32 (9) 1055;
You have access
CORRECTION TO “STUDIES ON THE METABOLISM OF THE NOVEL, SELECTIVE CYCLOOXYGENASE-2 INHIBITOR INDOMETHACIN PHENETHYLAMIDE IN RAT, MOUSE, AND HUMAN LIVER MICROSOMES: IDENTIFICATION OF ACTIVE METABOLITES”
Drug Metabolism and Disposition March 2004, 32 (3) 366; DOI: https://doi.org/10.1124/dmd.32.3.366

Pages